Skip to main content

Table 1 Clinical and laboratory characteristics before and after ALA treatment

From: α-Linolenic acid increases the G0/G1 switch gene 2 mRNA expression in peripheral blood mononuclear cells from obese patients: a pilot study

Parameters

Baseline

 

After 12 weeks

 

ALA (n = 14)

Control (n = 12)

p

ALA (n = 14)

Control (n = 12)

p

Age (years)

48.6 ± 6.8

49.3 ± 4.8

0.775

   

Body weight (kg)

93.6 ± 6.6

95.3 ± 6.6

0.329

89.8 ± 5.8

92.6 ± 6.7

0.265

BMI (kg/m2)

32.3 ± 1.2

32.7 ± 1.0

0.331

31.0 ± 1.3

31.8 ± 0.8

0.076

TC (mmol/L)

5.01 ± 0.48

5.17 ± 0.45

0.418

4.79 ± 0.42

5.01 ± 0.41

0.203

TG (mmol/L)

3.59 ± 0.65

3.73 ± 0.63

0.565

1.73 ± 0.31

2.63 ± 0.54

<0.0001*

FFA (μmol/L)

655 ± 324

662 ± 28

0.516

469 ± 29

501 ± 28

0.009*

Glycerol (μmol/L)

1505 ± 27

1538 ± 83

0.183

1028 ± 82

1201 ± 94

0.046*

IL-6 (ng/L)

2.34 ± 0.14

2.37 ± 0.15

0.603

1.53 ± 0.14

1.87 ± 0.12

<0.0001*

TNF-α (ng/L)

1.92 ± 0.14

1.92 ± 0.16

0.981

1.28 ± 0.10

1.63 ± 0.15

<0.0001*

  1. Data are means ± SD
  2. ALA vs Control, two-sample t test, *p < 0.05
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X